These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 28260166)
1. Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability. Malik PRV; Hamadeh A; Phipps C; Edginton AN J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):277-290. PubMed ID: 28260166 [TBL] [Abstract][Full Text] [Related]
2. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies. Glassman PM; Balthasar JP J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):427-46. PubMed ID: 27377311 [TBL] [Abstract][Full Text] [Related]
3. Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies. Reig-Lopez J; Tang W; Fernandez-Teruel C; Merino-Sanjuan M; Mangas-Sanjuan V; Boulton DW; Sharma P Br J Clin Pharmacol; 2023 Sep; 89(9):2691-2702. PubMed ID: 37055941 [TBL] [Abstract][Full Text] [Related]
4. Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys. Glassman PM; Chen Y; Balthasar JP J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):527-40. PubMed ID: 26364301 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of trastuzumab in patients with HER2+ metastatic breast cancer. Bruno R; Washington CB; Lu JF; Lieberman G; Banken L; Klein P Cancer Chemother Pharmacol; 2005 Oct; 56(4):361-9. PubMed ID: 15868146 [TBL] [Abstract][Full Text] [Related]
6. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations. Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic Physiologically Based Pharmacokinetic (PBPK) Model of the Heart Accounting for Inter-Individual Variability: Development and Performance Verification. Tylutki Z; Mendyk A; Polak S J Pharm Sci; 2018 Apr; 107(4):1167-1177. PubMed ID: 29175411 [TBL] [Abstract][Full Text] [Related]
8. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification. Krauss M; Burghaus R; Lippert J; Niemi M; Neuvonen P; Schuppert A; Willmann S; Kuepfer L; Görlitz L In Silico Pharmacol; 2013; 1():6. PubMed ID: 25505651 [TBL] [Abstract][Full Text] [Related]
9. Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory. Calvier EAM; Nguyen TT; Johnson TN; Rostami-Hodjegan A; Tibboel D; Krekels EHJ; Knibbe CAJ Pharm Res; 2018 Sep; 35(11):209. PubMed ID: 30218393 [TBL] [Abstract][Full Text] [Related]
10. Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice. Liu S; Humphreys SC; Cook KD; Conner KP; Correia AR; Jacobitz AW; Yang M; Primack R; Soto M; Padaki R; Lubomirski M; Smith R; Mock M; Thomas VA MAbs; 2023; 15(1):2263926. PubMed ID: 37824334 [TBL] [Abstract][Full Text] [Related]
11. Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data. Ocampo-Pelland AS; Gastonguay MR; French JF; Riggs MM J Pharmacokinet Pharmacodyn; 2016 Apr; 43(2):191-206. PubMed ID: 26872884 [TBL] [Abstract][Full Text] [Related]
12. Development of a PBPK model for monoclonal antibodies and simulation of human and mice PBPK of a radiolabelled monoclonal antibody. Heiskanen T; Heiskanen T; Kairemo K Curr Pharm Des; 2009; 15(9):988-1007. PubMed ID: 19275663 [TBL] [Abstract][Full Text] [Related]
13. Whole-Body Physiologically Based Pharmacokinetic Modeling of Trastuzumab and Prediction of Human Pharmacokinetics. Bae DJ; Kim SY; Bae SM; Hwang AK; Pak KC; Yoon S; Lim HS J Pharm Sci; 2019 Jun; 108(6):2180-2190. PubMed ID: 30716331 [TBL] [Abstract][Full Text] [Related]
14. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption. Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231 [TBL] [Abstract][Full Text] [Related]
15. Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling. Tiwari A; Abraham AK; Harrold JM; Zutshi A; Singh P AAPS J; 2017 Mar; 19(2):510-519. PubMed ID: 28004347 [TBL] [Abstract][Full Text] [Related]
16. Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery. Dallmann A; Himstedt A; Solodenko J; Ince I; Hempel G; Eissing T J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):341-359. PubMed ID: 32748112 [TBL] [Abstract][Full Text] [Related]
17. Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice. Li Z; Li Y; Chang HP; Yu X; Shah DK J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):743-762. PubMed ID: 34146191 [TBL] [Abstract][Full Text] [Related]
18. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. Fenneteau F; Poulin P; Nekka F J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982 [TBL] [Abstract][Full Text] [Related]
19. Modelling the effect of insulin on the disposal of meal-attributable glucose in type 1 diabetes. García-García F; Hovorka R; Wilinska ME; Elleri D; Hernando ME Med Biol Eng Comput; 2017 Feb; 55(2):271-282. PubMed ID: 27155940 [TBL] [Abstract][Full Text] [Related]
20. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. Garg A; Balthasar JP J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):687-709. PubMed ID: 17636457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]